 | • レポートコード：QYR2104Z2906 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、院内感染症管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断技術、洗浄・滅菌、治療）、用途別市場規模（総合病院、伝染病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・院内感染症管理の市場動向 ・企業の競争状況、市場シェア ・院内感染症管理の種類別市場規模（診断技術、洗浄・滅菌、治療） ・院内感染症管理の用途別市場規模（総合病院、伝染病院） ・院内感染症管理の北米市場規模2016-2027（アメリカ、カナダ） ・院内感染症管理のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・院内感染症管理のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・院内感染症管理の中南米市場規模2016-2027（メキシコ、ブラジル） ・院内感染症管理の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Advanced Sterilization Products、Becton Dickinson、Belimed AG、bioMerieux、Cantel、Cepheid、Getinge、Merck & Co.、Nordion、Pfizer、Roche、Sakura Seiki、Steris、TSO3） ・結論 |
Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.
Market Analysis and Insights: Global Hospital Acquired Infections Control Market
The global Hospital Acquired Infections Control market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Infections Control market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Acquired Infections Control market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Acquired Infections Control market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Acquired Infections Control market.
Global Hospital Acquired Infections Control Scope and Market Size
Hospital Acquired Infections Control market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections Control market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnostic techniques
Dleaning and sterilization
Treatment
Segment by Application
General Hospital
Infectious Disease Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Advanced Sterilization Products
Becton Dickinson
Belimed AG
bioMerieux
Cantel
Cepheid
Getinge
Merck & Co.
Nordion
bioMerieux
Cantel
Sakura Seiki
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infections Control Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostic techniques
1.2.3 Dleaning and sterilization
1.2.4 Treatment
1.3 Market by Application
1.3.1 Global Hospital Acquired Infections Control Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 General Hospital
1.3.3 Infectious Disease Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections Control Market Perspective (2016-2027)
2.2 Hospital Acquired Infections Control Growth Trends by Regions
2.2.1 Hospital Acquired Infections Control Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hospital Acquired Infections Control Historic Market Share by Regions (2016-2021)
2.2.3 Hospital Acquired Infections Control Forecasted Market Size by Regions (2022-2027)
2.3 Hospital Acquired Infections Control Industry Dynamic
2.3.1 Hospital Acquired Infections Control Market Trends
2.3.2 Hospital Acquired Infections Control Market Drivers
2.3.3 Hospital Acquired Infections Control Market Challenges
2.3.4 Hospital Acquired Infections Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections Control Players by Revenue
3.1.1 Global Top Hospital Acquired Infections Control Players by Revenue (2016-2021)
3.1.2 Global Hospital Acquired Infections Control Revenue Market Share by Players (2016-2021)
3.2 Global Hospital Acquired Infections Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Infections Control Revenue
3.4 Global Hospital Acquired Infections Control Market Concentration Ratio
3.4.1 Global Hospital Acquired Infections Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections Control Revenue in 2020
3.5 Hospital Acquired Infections Control Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Infections Control Product Solution and Service
3.7 Date of Enter into Hospital Acquired Infections Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Infections Control Breakdown Data by Type
4.1 Global Hospital Acquired Infections Control Historic Market Size by Type (2016-2021)
4.2 Global Hospital Acquired Infections Control Forecasted Market Size by Type (2022-2027)
5 Hospital Acquired Infections Control Breakdown Data by Application
5.1 Global Hospital Acquired Infections Control Historic Market Size by Application (2016-2021)
5.2 Global Hospital Acquired Infections Control Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hospital Acquired Infections Control Market Size (2016-2027)
6.2 North America Hospital Acquired Infections Control Market Size by Type
6.2.1 North America Hospital Acquired Infections Control Market Size by Type (2016-2021)
6.2.2 North America Hospital Acquired Infections Control Market Size by Type (2022-2027)
6.2.3 North America Hospital Acquired Infections Control Market Size by Type (2016-2027)
6.3 North America Hospital Acquired Infections Control Market Size by Application
6.3.1 North America Hospital Acquired Infections Control Market Size by Application (2016-2021)
6.3.2 North America Hospital Acquired Infections Control Market Size by Application (2022-2027)
6.3.3 North America Hospital Acquired Infections Control Market Size by Application (2016-2027)
6.4 North America Hospital Acquired Infections Control Market Size by Country
6.4.1 North America Hospital Acquired Infections Control Market Size by Country (2016-2021)
6.4.2 North America Hospital Acquired Infections Control Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Hospital Acquired Infections Control Market Size (2016-2027)
7.2 Europe Hospital Acquired Infections Control Market Size by Type
7.2.1 Europe Hospital Acquired Infections Control Market Size by Type (2016-2021)
7.2.2 Europe Hospital Acquired Infections Control Market Size by Type (2022-2027)
7.2.3 Europe Hospital Acquired Infections Control Market Size by Type (2016-2027)
7.3 Europe Hospital Acquired Infections Control Market Size by Application
7.3.1 Europe Hospital Acquired Infections Control Market Size by Application (2016-2021)
7.3.2 Europe Hospital Acquired Infections Control Market Size by Application (2022-2027)
7.3.3 Europe Hospital Acquired Infections Control Market Size by Application (2016-2027)
7.4 Europe Hospital Acquired Infections Control Market Size by Country
7.4.1 Europe Hospital Acquired Infections Control Market Size by Country (2016-2021)
7.4.2 Europe Hospital Acquired Infections Control Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infections Control Market Size (2016-2027)
8.2 Asia-Pacific Hospital Acquired Infections Control Market Size by Type
8.2.1 Asia-Pacific Hospital Acquired Infections Control Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hospital Acquired Infections Control Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hospital Acquired Infections Control Market Size by Type (2016-2027)
8.3 Asia-Pacific Hospital Acquired Infections Control Market Size by Application
8.3.1 Asia-Pacific Hospital Acquired Infections Control Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hospital Acquired Infections Control Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hospital Acquired Infections Control Market Size by Application (2016-2027)
8.4 Asia-Pacific Hospital Acquired Infections Control Market Size by Region
8.4.1 Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hospital Acquired Infections Control Market Size (2016-2027)
9.2 Latin America Hospital Acquired Infections Control Market Size by Type
9.2.1 Latin America Hospital Acquired Infections Control Market Size by Type (2016-2021)
9.2.2 Latin America Hospital Acquired Infections Control Market Size by Type (2022-2027)
9.2.3 Latin America Hospital Acquired Infections Control Market Size by Type (2016-2027)
9.3 Latin America Hospital Acquired Infections Control Market Size by Application
9.3.1 Latin America Hospital Acquired Infections Control Market Size by Application (2016-2021)
9.3.2 Latin America Hospital Acquired Infections Control Market Size by Application (2022-2027)
9.3.3 Latin America Hospital Acquired Infections Control Market Size by Application (2016-2027)
9.4 Latin America Hospital Acquired Infections Control Market Size by Country
9.4.1 Latin America Hospital Acquired Infections Control Market Size by Country (2016-2021)
9.4.2 Latin America Hospital Acquired Infections Control Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infections Control Market Size (2016-2027)
10.2 Middle East & Africa Hospital Acquired Infections Control Market Size by Type
10.2.1 Middle East & Africa Hospital Acquired Infections Control Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hospital Acquired Infections Control Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hospital Acquired Infections Control Market Size by Type (2016-2027)
10.3 Middle East & Africa Hospital Acquired Infections Control Market Size by Application
10.3.1 Middle East & Africa Hospital Acquired Infections Control Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hospital Acquired Infections Control Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hospital Acquired Infections Control Market Size by Application (2016-2027)
10.4 Middle East & Africa Hospital Acquired Infections Control Market Size by Country
10.4.1 Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Advanced Sterilization Products
11.1.1 Advanced Sterilization Products Company Details
11.1.2 Advanced Sterilization Products Business Overview
11.1.3 Advanced Sterilization Products Hospital Acquired Infections Control Introduction
11.1.4 Advanced Sterilization Products Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.1.5 Advanced Sterilization Products Recent Development
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Details
11.2.2 Becton Dickinson Business Overview
11.2.3 Becton Dickinson Hospital Acquired Infections Control Introduction
11.2.4 Becton Dickinson Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.2.5 Becton Dickinson Recent Development
11.3 Belimed AG
11.3.1 Belimed AG Company Details
11.3.2 Belimed AG Business Overview
11.3.3 Belimed AG Hospital Acquired Infections Control Introduction
11.3.4 Belimed AG Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.3.5 Belimed AG Recent Development
11.4 bioMerieux
11.4.1 bioMerieux Company Details
11.4.2 bioMerieux Business Overview
11.4.3 bioMerieux Hospital Acquired Infections Control Introduction
11.4.4 bioMerieux Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.4.5 bioMerieux Recent Development
11.5 Cantel
11.5.1 Cantel Company Details
11.5.2 Cantel Business Overview
11.5.3 Cantel Hospital Acquired Infections Control Introduction
11.5.4 Cantel Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.5.5 Cantel Recent Development
11.6 Cepheid
11.6.1 Cepheid Company Details
11.6.2 Cepheid Business Overview
11.6.3 Cepheid Hospital Acquired Infections Control Introduction
11.6.4 Cepheid Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.6.5 Cepheid Recent Development
11.7 Getinge
11.7.1 Getinge Company Details
11.7.2 Getinge Business Overview
11.7.3 Getinge Hospital Acquired Infections Control Introduction
11.7.4 Getinge Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.7.5 Getinge Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Details
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Hospital Acquired Infections Control Introduction
11.8.4 Merck & Co. Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.8.5 Merck & Co. Recent Development
11.9 Nordion
11.9.1 Nordion Company Details
11.9.2 Nordion Business Overview
11.9.3 Nordion Hospital Acquired Infections Control Introduction
11.9.4 Nordion Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.9.5 Nordion Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Hospital Acquired Infections Control Introduction
11.10.4 Pfizer Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Hospital Acquired Infections Control Introduction
11.11.4 Roche Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Sakura Seiki
11.12.1 Sakura Seiki Company Details
11.12.2 Sakura Seiki Business Overview
11.12.3 Sakura Seiki Hospital Acquired Infections Control Introduction
11.12.4 Sakura Seiki Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.12.5 Sakura Seiki Recent Development
11.13 Steris
11.13.1 Steris Company Details
11.13.2 Steris Business Overview
11.13.3 Steris Hospital Acquired Infections Control Introduction
11.13.4 Steris Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.13.5 Steris Recent Development
11.14 TSO3
11.14.1 TSO3 Company Details
11.14.2 TSO3 Business Overview
11.14.3 TSO3 Hospital Acquired Infections Control Introduction
11.14.4 TSO3 Revenue in Hospital Acquired Infections Control Business (2016-2021)
11.14.5 TSO3 Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hospital Acquired Infections Control Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnostic techniques
Table 3. Key Players of Dleaning and sterilization
Table 4. Key Players of Treatment
Table 5. Global Hospital Acquired Infections Control Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hospital Acquired Infections Control Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hospital Acquired Infections Control Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hospital Acquired Infections Control Market Share by Regions (2016-2021)
Table 9. Global Hospital Acquired Infections Control Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hospital Acquired Infections Control Market Share by Regions (2022-2027)
Table 11. Hospital Acquired Infections Control Market Trends
Table 12. Hospital Acquired Infections Control Market Drivers
Table 13. Hospital Acquired Infections Control Market Challenges
Table 14. Hospital Acquired Infections Control Market Restraints
Table 15. Global Hospital Acquired Infections Control Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hospital Acquired Infections Control Market Share by Players (2016-2021)
Table 17. Global Top Hospital Acquired Infections Control Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infections Control as of 2020)
Table 18. Ranking of Global Top Hospital Acquired Infections Control Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hospital Acquired Infections Control Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hospital Acquired Infections Control Product Solution and Service
Table 22. Date of Enter into Hospital Acquired Infections Control Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hospital Acquired Infections Control Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hospital Acquired Infections Control Revenue Market Share by Type (2016-2021)
Table 26. Global Hospital Acquired Infections Control Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hospital Acquired Infections Control Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hospital Acquired Infections Control Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hospital Acquired Infections Control Revenue Market Share by Application (2016-2021)
Table 30. Global Hospital Acquired Infections Control Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hospital Acquired Infections Control Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hospital Acquired Infections Control Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hospital Acquired Infections Control Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hospital Acquired Infections Control Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hospital Acquired Infections Control Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hospital Acquired Infections Control Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hospital Acquired Infections Control Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hospital Acquired Infections Control Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hospital Acquired Infections Control Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hospital Acquired Infections Control Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hospital Acquired Infections Control Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hospital Acquired Infections Control Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hospital Acquired Infections Control Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hospital Acquired Infections Control Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hospital Acquired Infections Control Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hospital Acquired Infections Control Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hospital Acquired Infections Control Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hospital Acquired Infections Control Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hospital Acquired Infections Control Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hospital Acquired Infections Control Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hospital Acquired Infections Control Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hospital Acquired Infections Control Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hospital Acquired Infections Control Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hospital Acquired Infections Control Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hospital Acquired Infections Control Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hospital Acquired Infections Control Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hospital Acquired Infections Control Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2022-2027) & (US$ Million)
Table 62. Advanced Sterilization Products Company Details
Table 63. Advanced Sterilization Products Business Overview
Table 64. Advanced Sterilization Products Hospital Acquired Infections Control Product
Table 65. Advanced Sterilization Products Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 66. Advanced Sterilization Products Recent Development
Table 67. Becton Dickinson Company Details
Table 68. Becton Dickinson Business Overview
Table 69. Becton Dickinson Hospital Acquired Infections Control Product
Table 70. Becton Dickinson Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 71. Becton Dickinson Recent Development
Table 72. Belimed AG Company Details
Table 73. Belimed AG Business Overview
Table 74. Belimed AG Hospital Acquired Infections Control Product
Table 75. Belimed AG Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 76. Belimed AG Recent Development
Table 77. bioMerieux Company Details
Table 78. bioMerieux Business Overview
Table 79. bioMerieux Hospital Acquired Infections Control Product
Table 80. bioMerieux Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 81. bioMerieux Recent Development
Table 82. Cantel Company Details
Table 83. Cantel Business Overview
Table 84. Cantel Hospital Acquired Infections Control Product
Table 85. Cantel Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 86. Cantel Recent Development
Table 87. Cepheid Company Details
Table 88. Cepheid Business Overview
Table 89. Cepheid Hospital Acquired Infections Control Product
Table 90. Cepheid Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 91. Cepheid Recent Development
Table 92. Getinge Company Details
Table 93. Getinge Business Overview
Table 94. Getinge Hospital Acquired Infections Control Product
Table 95. Getinge Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 96. Getinge Recent Development
Table 97. Merck & Co. Company Details
Table 98. Merck & Co. Business Overview
Table 99. Merck & Co. Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 100. Merck & Co. Recent Development
Table 101. Nordion Company Details
Table 102. Nordion Business Overview
Table 103. Nordion Hospital Acquired Infections Control Product
Table 104. Nordion Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 105. Nordion Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Hospital Acquired Infections Control Product
Table 109. Pfizer Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 110. Pfizer Recent Development
Table 111. Roche Company Details
Table 112. Roche Business Overview
Table 113. Roche Hospital Acquired Infections Control Product
Table 114. Roche Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 115. Roche Recent Development
Table 116. Sakura Seiki Company Details
Table 117. Sakura Seiki Business Overview
Table 118. Sakura Seiki Hospital Acquired Infections Control Product
Table 119. Sakura Seiki Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 120. Sakura Seiki Recent Development
Table 121. Steris Company Details
Table 122. Steris Business Overview
Table 123. Steris Hospital Acquired Infections Control Product
Table 124. Steris Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 125. Steris Recent Development
Table 126. TSO3 Company Details
Table 127. TSO3 Business Overview
Table 128. TSO3 Hospital Acquired Infections Control Product
Table 129. TSO3 Revenue in Hospital Acquired Infections Control Business (2016-2021) & (US$ Million)
Table 130. TSO3 Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Infections Control Market Share by Type: 2020 VS 2027
Figure 2. Diagnostic techniques Features
Figure 3. Dleaning and sterilization Features
Figure 4. Treatment Features
Figure 5. Global Hospital Acquired Infections Control Market Share by Application: 2020 VS 2027
Figure 6. General Hospital Case Studies
Figure 7. Infectious Disease Hospital Case Studies
Figure 8. Hospital Acquired Infections Control Report Years Considered
Figure 9. Global Hospital Acquired Infections Control Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hospital Acquired Infections Control Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hospital Acquired Infections Control Market Share by Regions: 2020 VS 2027
Figure 12. Global Hospital Acquired Infections Control Market Share by Regions (2022-2027)
Figure 13. Global Hospital Acquired Infections Control Market Share by Players in 2020
Figure 14. Global Top Hospital Acquired Infections Control Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infections Control as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hospital Acquired Infections Control Revenue in 2020
Figure 16. Global Hospital Acquired Infections Control Revenue Market Share by Type (2016-2021)
Figure 17. Global Hospital Acquired Infections Control Revenue Market Share by Type (2022-2027)
Figure 18. North America Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hospital Acquired Infections Control Market Share by Type (2016-2027)
Figure 20. North America Hospital Acquired Infections Control Market Share by Application (2016-2027)
Figure 21. North America Hospital Acquired Infections Control Market Share by Country (2016-2027)
Figure 22. United States Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hospital Acquired Infections Control Market Share by Type (2016-2027)
Figure 26. Europe Hospital Acquired Infections Control Market Share by Application (2016-2027)
Figure 27. Europe Hospital Acquired Infections Control Market Share by Country (2016-2027)
Figure 28. Germany Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hospital Acquired Infections Control Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hospital Acquired Infections Control Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hospital Acquired Infections Control Market Share by Region (2016-2027)
Figure 38. China Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hospital Acquired Infections Control Market Share by Type (2016-2027)
Figure 46. Latin America Hospital Acquired Infections Control Market Share by Application (2016-2027)
Figure 47. Latin America Hospital Acquired Infections Control Market Share by Country (2016-2027)
Figure 48. Mexico Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hospital Acquired Infections Control Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hospital Acquired Infections Control Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hospital Acquired Infections Control Market Share by Country (2016-2027)
Figure 54. Turkey Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hospital Acquired Infections Control Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Advanced Sterilization Products Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 58. Becton Dickinson Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 59. Belimed AG Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 60. bioMerieux Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 61. Cantel Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 62. Cepheid Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 63. Getinge Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 64. Merck & Co. Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 65. Nordion Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 68. Sakura Seiki Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 69. Steris Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 70. TSO3 Revenue Growth Rate in Hospital Acquired Infections Control Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の院内感染症管理市場規模・現状・予測（2021年-2027年） Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acq…- 世界の院内感染症（HAI）診断市場規模・現状・予測（2021年-2027年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…
- 世界の院内感染症検査市場規模・現状・予測（2021年-2027年） Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, b…
- 世界の院内感染症治療市場規模・現状・予測（2021年-2027年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 21430 million b…
- 世界の院内感染症検査市場規模・現状・予測（2021年-2027年） Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections…